Detalhe da pesquisa
1.
Emerging Cellular Therapies for Cancer.
Annu Rev Immunol
; 37: 145-171, 2019 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30526160
2.
An NK-like CAR T cell transition in CAR T cell dysfunction.
Cell
; 184(25): 6081-6100.e26, 2021 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34861191
3.
Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia.
Cell
; 173(6): 1439-1453.e19, 2018 05 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-29856956
4.
Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells.
Immunity
; 56(10): 2388-2407.e9, 2023 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37776850
5.
Exploiting the CD200-CD200R immune checkpoint axis in multiple myeloma to enhance CAR T-cell therapy.
Blood
; 143(2): 139-151, 2024 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37616575
6.
DLBCL-associated NOTCH2 mutations escape ubiquitin-dependent degradation and promote chemoresistance.
Blood
; 142(11): 973-988, 2023 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37235754
7.
Alternative splicing of its 5'-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapies.
Blood
; 142(20): 1724-1739, 2023 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37683180
8.
Immunologic predictors of vaccine responsiveness in patients with lymphoma and CLL.
J Infect Dis
; 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38437622
9.
Pembrolizumab for B-cell lymphomas relapsing after or refractory to CD19-directed CAR T-cell therapy.
Blood
; 139(7): 1026-1038, 2022 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34496014
10.
Streamlined measurement of chimeric antigen receptor T-cell concentration, size, viability and two-color phenotyping during manufacturing.
Cytotherapy
; 26(5): 506-511, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38483365
11.
Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy.
Mol Ther
; 31(3): 686-700, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36641624
12.
Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study.
Mol Cancer
; 22(1): 200, 2023 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38066564
13.
The "Great Debate" at Immunotherapy Bridge 2022, Naples, November 30th-December 1st, 2022.
J Transl Med
; 21(1): 275, 2023 04 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37087493
14.
Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st-2nd, 2021.
J Transl Med
; 20(1): 257, 2022 06 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35672823
15.
A cellular antidote to specifically deplete anti-CD19 chimeric antigen receptor-positive cells.
Blood
; 135(7): 505-509, 2020 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31703119
16.
CAR-T TREK through the lymphoma universe, to boldly go where no other therapy has gone before.
Br J Haematol
; 193(3): 449-465, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33222167
17.
Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas.
Haematologica
; 106(6): 1705-1713, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32414850
18.
The long road to the first FDA-approved gene therapy: chimeric antigen receptor T cells targeting CD19.
Cytotherapy
; 22(2): 57-69, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32014447
19.
Influence of Donor and Recipient Gender on Telomere Maintenance after Umbilical Cord Blood Cell Transplantation: A Study by the Gruppo Italiano Trapianto Di Midollo Osseo.
Biol Blood Marrow Transplant
; 25(7): 1387-1394, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30935966
20.
Five-Year Outcomes for Refractory B-Cell Lymphomas with CAR T-Cell Therapy.
N Engl J Med
; 384(7): 673-674, 2021 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33596362